作者：
Font,R. [1]
;
Espinas,J.A. [2]
;
Gil-Gil,M. [3]
;
Barnadas,A. [4]
;
Ojeda,B. [5]
;
Tusquets,I. [6]
;
Segui,M.A. [7]
;
Margelí,M. [8]
;
Arcusa,A. [9]
;
Prat,A. ;
Garcia,M. ;
Borras,J.M.
作者单位：
Pharmaceutical Care and Complementary Benefits, Catalonia Health Service, Department of Health
[1]
Department of Medical Oncology, Del Mar Hospital, Passeig Marítim 25-29, Barcelona 08003, Spain
[2]
Cancer Prevention and Control Group, Bellvitge Biomedical Research Institute, Catalonian Institute
[3]
Department of Medical Oncology, Germans Trias i Pujol Hospital, ICO-Badalona, Carretera de Canyet s
[4]
Department of Medical Oncology, Terrassa Health Consortium, Torrebonica s/n, Terrassa 08227, Spain
[5]
Catalonian Cancer Strategy Unit, Department of Health, Catalonian Regional Authority, Gran Via de l
[6]
Department of Medical Oncology, Bellvitge Biomedical Research Institute, Catalonian Institute of
[7]
Department of Medical Oncology, Parc Taulí Health Corporation, Carretera de Prats de Llu?anés 166
[8]
Department of Medical Oncology, Santa Creu i Sant Pau Hospital, Sant Antoni Maria Claret 167
[9]
发布时间
2013-11-20
换一批
